Gestonorone caproate

This classification denotes a therapeutic progestin with the molecular formula C20H28O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H4G605B7VP, chemically known as 19-norpregn-4-ene-3,20-dione, 17-hydroxy- but more generally known as gestonorone, which bears US NIH Compound Identifier 102210. European Medicines Agency schedules Gestonorone caproate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07902MIG. The term GESTONORONE CAPROATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules gestonorone in its Anatomical Therapeutic Chemical (ATC) Classification. GESTONORONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule gestonorone caproate under HS 29372300 and SITC 54153. As of Q4 2014, GESTONORONE CAPROATE remains US FDA's Preferred Term for this commodity. Gestonorone caproate bears US NLM identifiers UMLS ID C0017505 and NCI Concept Code C74365. SMILES: CCCCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)C(=O)C.